FoundersInvestorsMediaCareersContact
Home / Portfolio / Allergenix

Biotech · Incorporate

Allergenix

Allergy diagnostics and immunotherapy built around the regional allergen profile.

StageIncorporate
Co-founded2025
OriginStudio-formed
FocusRegional allergen profile

The problem

Imported allergy panels are built around European and North American allergens. The Gulf's dominant allergens — regional pollens, dust profiles, dietary patterns — are underrepresented or absent, so patients test negative and stay undiagnosed.

Our approach

A panel designed from the regional allergen profile up, with an immunotherapy path attached rather than diagnostics alone.

Where it stands

Entity live, first capital deployed. Panel design in progress.

Stage descriptions reflect the studio's internal classification and are updated quarterly. Regulatory status is determined solely by the Saudi Food and Drug Authority.

Sign up for the studio letter

Quarterly, from Riyadh: what we incorporated, what cleared the SFDA, and what is opening to outside capital.

Sign up